<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03566342</url>
  </required_header>
  <id_info>
    <org_study_id>IRB #08/08/VA07</org_study_id>
    <nct_id>NCT03566342</nct_id>
  </id_info>
  <brief_title>Optimal Regimen of Patient-controlled Epidural Analgesia in Laboring Patients</brief_title>
  <acronym>PCEA</acronym>
  <official_title>Optimal Regimen of Patient-controlled Epidural Analgesia in Laboring Patients Receiving Combined Spinal and Epidural Analgesia (CSE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maimonides Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maimonides Medical Center</source>
  <brief_summary>
    <textblock>
      To test the efficacy of different recipes of epidural infusions used for providing pain
      relief during labor in parturients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this prospective trial, the investigators would like to examine the efficacy of several
      different PCEA protocols in 250 parturients who receive CSE for labor pain. Any patient with
      failed epidural, delivery within 2 hours of epidural insertion, or Cesarean section will be
      excluded from the study. Each patient will be assigned to one of five groups (A - E),
      depending on the day of admission for delivery, excluding Friday and Saturday (observed
      religious holidays). Each group will have 50 patients.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Preliminary analysis of data showed no significant findings
  </why_stopped>
  <start_date>August 2007</start_date>
  <completion_date type="Actual">July 2015</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Days</target_duration>
  <primary_outcome>
    <measure>Pain scores</measure>
    <time_frame>24 to 48 hours.</time_frame>
    <description>From each patient investigators will collect pain scores to assess the severity of labor pain, using the Visual Analog Scale (VAS) scale, 1-10. VAS score of 1 is considered minimal pain and VAS score of 10 is considered as the maximum pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of boluses</measure>
    <time_frame>24 to 48 hours</time_frame>
    <description>From each patient the investigators will obtain information on total number of boluses of the epidural medication used</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of medication used</measure>
    <time_frame>24 to 48 hours</time_frame>
    <description>From each patient the investigators will obtain information regarding the total amount of medications used in mls from reviewing the history on the PCEA pump.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor block</measure>
    <time_frame>24 to 48 hours.</time_frame>
    <description>For each patient, the investigators will obtain information regarding degree of motor block using the Modified Bromage scale.
Modified Bromage score:
Complete block (unable to move feet or knees)
Almost complete block (able to move feet only)
Partial block (just able to move knees)
Detectable weakness of hip flexion while supine (full flexion of knees)
No detectable weakness of hip flexion while supine
Able to perform partial knee bend</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Height of the patient</measure>
    <time_frame>At recruitment of the patient in to the study</time_frame>
    <description>From each patient the investigators will obtain information on height in inches.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight of the patient</measure>
    <time_frame>At recruitment of the patient in to the study</time_frame>
    <description>From each patient the investigators will obtain information on weight in pounds</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall patient satisfaction</measure>
    <time_frame>24 to 48 hours</time_frame>
    <description>From each patient investigators will collect satisfaction scores to assess degree of satisfaction, using the Visual Analog Scale (VAS) scale, 1-10. VAS score of 1 is considered minimal satisfaction and VAS score of 10 is considered as the maximum satisfaction.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mode of delivery</measure>
    <time_frame>24 to 48 hours</time_frame>
    <description>From each patient the investigators will obtain information regarding mode of delivery- vaginal delivery or C-Section</description>
  </secondary_outcome>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Actual">145</enrollment>
  <condition>LABOR PAIN</condition>
  <arm_group>
    <arm_group_label>GROUP A</arm_group_label>
    <description>The PCEA solution will contain 0.1% Bupivacaine + 2.85 mcg/cc of Fentanyl. Basal infusion 7 ml/hour Demand dose 8ml Lockout ( number of doses per hour) 2 Lock out interval 30 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GROUP B</arm_group_label>
    <description>The PCEA solution will contain 0.1% Bupivacaine + 2.85 mcg/cc of Fentanyl. Basal infusion 7 ml/hour Demand dose 5ml Lockout ( number of doses per hour) 4 Lock out interval 15 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GROUP C</arm_group_label>
    <description>The PCEA solution will contain 0.1% Bupivacaine + 2.85 mcg/cc of Fentanyl. Basal infusion 7 ml/hour Demand dose 3ml Lockout ( number of doses per hour) 6 Lock out interval 10 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GROUP D</arm_group_label>
    <description>The PCEA solution will contain 0.1% Bupivacaine + 2.85 mcg/cc of Fentanyl. Basal infusion 14 ml/hour Demand dose 0 ml Lockout ( number of doses per hour) 0 Lock out interval 0 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GROUP E</arm_group_label>
    <description>The PCEA solution will contain 0.1% Bupivacaine + 2.85 mcg/cc of Fentanyl. Basal infusion 7 ml/hour Demand dose 7ml Lockout ( number of doses per hour) 3 Lock out interval 20 minutes</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Laboring women receiving combined spinal epidural analgesia for pain relief
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Parturients receiving Combined Spinal epidural analgesia for labor pain relief.

        Exclusion Criteria:

        Any patient with failed epidural, delivery within 2 hours of epidural insertion, or
        Cesarean section will be excluded from the study.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>pregnant females</gender_description>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>KALPANA TYAGARAJ</last_name>
    <role>Principal Investigator</role>
    <affiliation>MAIMONIDES MEDICAL CENTER, 4802, 10TH AVENUE, BROOKLYN, NY-11219</affiliation>
  </overall_official>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>April 6, 2018</study_first_submitted>
  <study_first_submitted_qc>June 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 25, 2018</study_first_posted>
  <last_update_submitted>June 20, 2018</last_update_submitted>
  <last_update_submitted_qc>June 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Maimonides Medical Center</investigator_affiliation>
    <investigator_full_name>kalpana tyagaraj</investigator_full_name>
    <investigator_title>Residency Program Director</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Labor Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

